Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.
Today, we focus on Diagnos (ADK.V) which leverages proprietary AI technology and retinal scanning to revolutionize diagnosis methodology for such conditions as diabetes.
Enjoy!